Form 4: Fulton Financial Director Sells Shares Under 10b5-1 Plan

Fulton Financial Director E. Philip Wenger sold 5,000 shares of common stock for $19.2775 per share under a pre-arranged trading plan.

Summary

• E. Philip Wenger, a Director of Fulton Financial Corp, reported a transaction involving the company's common stock.
• On September 12, 2025, Wenger sold 5,000 shares of $2.50 par value common stock.
• The shares were sold at a weighted average price of $19.2775 per share, with individual transaction prices ranging from $19.200 to $19.320.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
• Following the transaction, Wenger directly holds 579,102.0447 shares, which includes 121,296.5261 shares held jointly with a spouse.
• Indirect beneficial ownership includes 90,477 shares held by an IRA and 447.9853 shares held by children.

Sentiment

Score: 5

Explanation: The transaction represents a routine insider sale executed under a pre-arranged 10b5-1 trading plan, which typically mitigates concerns about opportunistic selling. The volume is not exceptionally large relative to total holdings, indicating a neutral impact.

Negatives

• A director selling shares, even under a pre-planned arrangement, can sometimes be perceived negatively by some investors.

Industry Context

This filing reports a routine insider transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: A director's sale of shares, even pre-planned, might lead to minor sentiment shifts, but the volume is unlikely to have a significant impact on the company's valuation or investor confidence.

Key Dates

Recommendation

The reported transaction is a routine insider sale by a director, executed under a pre-established Rule 10b5-1 trading plan. Such plans are designed to allow insiders to sell shares without being accused of trading on material non-public information. The volume of shares sold (5,000) is not substantial enough to indicate a significant change in the director's conviction about the company's future or to materially impact the stock's valuation. Therefore, this specific filing does not provide new information that would warrant a change from a 'hold' recommendation. Investors should continue to evaluate Fulton Financial based on its broader financial performance, strategic initiatives, and market conditions.

Keywords

Fulton Financial, FULT, Insider Transaction, Form 4, Stock Sale, E Philip Wenger, 10b5-1 Plan